Article

New Daily Persistent Headache—Not So Rare, Especially in Adolescents


 

References

Treatment Options
There are very little treatment data, Dr. Markley pointed out. “There’s only experience, and it’s very difficult.” The benign form goes away by itself, so it doesn’t need therapy. The refractory form can be totally intractable even to the most aggressive treatment. Some evidence, however, suggests that some of these patients may respond to topiramate or gabapentin. “But the gabapentin does need to be quite high, almost 3 grams a day, and again there are anecdotal reports only,” he noted. In Dr. Markley’s practice, “we have an algorithm when we see patients like this, even teenagers. We start with riboflavin 200 mg bid for a minimum of six weeks, we have them keep a headache diary, and then they come back in six weeks and we see what the pattern looks like. Then we add topiramate, [increasing the dose] by 15 mg per week, up to as high as 200 mg/day, with a minimum of eight weeks at Dmax.”

Next Dr. Markley suggests adding gabapentin 400 to 800 mg weekly, up to 3 g/day. Split doses, he noted, improve absorption. “If we find we’re dealing with the most severe form of the disorder we go on to botulinum toxin, three rounds of treatment, 100 units each. And at the end, at least adult patients are getting occipital nerve stimulators.” Anecdotal reports, he said, indicate that occipital nerve stimulation may be dramatically effective for this type of headache. If headaches substantially improve or stop, Dr. Markley recommends maintaining the last level of treatment for at least six months and then taper.

No Magic Bullet
Treatment of new daily persistent headache is difficult. Pharmacotherapy can include antidepressants and anticonvulsants. Nondrug treatment can include biofeedback, relaxation, and cognitive therapy. These patients should be seen in a headache clinic or specialized care center, and inpatient treatment is sometimes indicated. Multiple therapies, and multidisciplinary care, are required.

—Glenn S. Williams

Pages

Recommended Reading

Low Estrogen Levels Trigger Menstrual Migraine
MDedge Neurology
Migraines Linked to Stroke and Vascular Disease Risk in Pregnant Women
MDedge Neurology
Does Medication Overuse Affect School Attendance?
MDedge Neurology
Portable Device Proves Safe and Effective in Reducing Pain in Migraine With Aura
MDedge Neurology
Novel CGRP Receptor Antagonist Relieves Migraine Pain
MDedge Neurology
Mild Head Injuries Pose Risk for Posttraumatic Headaches in Combat Veterans
MDedge Neurology
Do Weather Conditions Trigger Severe Headaches?
MDedge Neurology
Glial Cells—A New Target for Chronic Pain Treatment
MDedge Neurology
Multiple Factors Influence the Placebo Response and Effect in Headache Patients
MDedge Neurology
How Triptans Have Transformed the Acute Treatment of Migraine
MDedge Neurology